Clinical Trial: An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to show the effectiveness of PRO-513 for associated symptoms of nausea, photophobia, and phonophobia due to a migraine attack.
Detailed Summary:
Sponsor: ProEthic Pharmaceuticals
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: ProEthic Pharmaceuticals
Dates:
Date Received: May 26, 2006
Date Started: May 2006
Date Completion: December 2006
Last Updated: March 30, 2007
Last Verified: March 2007